Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 17Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 11Leukemia, Megakaryoblastic, Acute 11Leukemia, Erythroblastic, Acute 11Breast Neoplasms 11Congenital Abnormalities 9Leukemia 7Glioblastoma 7Recurrence 6Pancreatic Neoplasms 6Multiple Myeloma 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Gliosarcoma 5Carcinoma, Non-Small-Cell Lung 5Anemia, Refractory, with Excess of Blasts 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Breast Neoplasms, Male 4Brain Neoplasms 4Blast Crisis 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Melanoma 3

Interventions

tipifarnib 1soybean oil, phospholipid emulsion 1penpulimab 1Sunscreening Agents 1Spironolactone 1Sorafenib 1Rifampin 1Morphine 1Methods 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hydrocortisone 1Genetic Testing 1Genetic Counseling 1Fat Emulsions, Intravenous 1Educational Status 1Early Intervention, Educational 1Doxycycline 1Docetaxel 1Counseling 1Cordotomy 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Neoplasm × tipifarnib × Clear all
NCT00244972 2017-04-27

Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Completed
74 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡